cas 618090-91-8|| where to buy 1-(4-Methylphenyl)-5-(trifluoromethyl)-1H-pyrazole-4-carbohydrazide

Product Name:1-(4-Methylphenyl)-5-(trifluoromethyl)-1H-pyrazole-4-carbohydrazide

IUPAC Name:1-(4-methylphenyl)-5-(trifluoromethyl)-1H-pyrazole-4-carbohydrazide

Packing Unit	Available Stock	Price($)	Quantity
CM522917-1g	in stock	ǆƚƚ

For R&D use only.

Inquiry Form

Chemical Name

CAS Number

Quantity*

Required Specifications*
(Assay %, Material Grade etc.)

Contact Name*

Contact Email*

Additional Notes

Verification code*

refresh

: CAS NO:618090-91-8; Molecular Formula:C12H11F3N4O; Melting Point:-; Smiles Code:O=C(C1=C(C(F)(F)F)N(C2=CC=C(C)C=C2)N=C1)NN; Density:

: Catalog Number:CM522917; Molecular Weight:284.24; Boiling Point:; MDL No:MFCD03934815; Storage:

: Pyrazoles; Pyrazoles are organic compounds of the general formula C3H3N2H. It is a five-membered heterocycle consisting of three carbon atoms and two adjacent nitrogen atoms. As an H-bond-donating heterocycle, pyrazole has been used as a more lipophilic and metabolically more stable bioisomer of phenol. Pyrazoles have attracted more and more attention due to their broad spectrum of action and strong efficacy.; Pyrazone; Custom pyrazone for customers from all over the world are our main business.

Product Overview	1-(4-Methylphenyl)-5-(trifluoromethyl)-1H-pyrazole-4-carbohydrazide is a chemical compound that has gained significant attention in scientific research due to its potential applications in medicinal chemistry. This compound is commonly referred to as MPTC and has been found to exhibit interesting biochemical and physiological effects.
Synthesis and Application	The synthesis of MPTC involves the reaction of 4-methylphenylhydrazine with 5-(trifluoromethyl)-1H-pyrazole-4-carboxylic acid in the presence of a coupling agent such as EDCI or DCC. The resulting product is then purified by recrystallization to obtain MPTC in high purity. MPTC has been found to exhibit potential applications in medicinal chemistry due to its ability to inhibit the activity of certain enzymes such as carbonic anhydrase and acetylcholinesterase. This inhibition can lead to the development of drugs for the treatment of various diseases such as glaucoma, Alzheimer's disease, and epilepsy.
Future Directions	Future research on MPTC could focus on its potential applications in the treatment of cancer, cardiovascular disease, and neurodegenerative diseases. Additionally, research could focus on developing derivatives of MPTC with improved selectivity and decreased cytotoxicity. Finally, research could focus on the development of drug delivery systems for MPTC to improve its bioavailability and efficacy.